Bayer launches Aleve PM; Canada green-lights BMS' Yervoy;

> Bayer has launched Aleve PM, a pain reliever and sleep-aid combo. Release

> Health Canada has approved Bristol-Myers Squibb's ($BMY) Yervoy for first-line treatment of adults with metastatic melanoma. Release

> Novo Nordisk's ($NVO) new long-acting insulin, Tresiba, is effective and safe for long-term use in children and young adults with Type 1 diabetes, a new study shows. Report

> Danish drugmaker Lundbeck has launched antidepressant Brintellix in its home market, its first EU rollout. Report

> AbbVie ($ABBV) and Biogen Idec's ($BIIB) experimental multiple sclerosis med Zinbryta topped Biogen's Avonex on some measures in a Phase III trial. More

> Almost 90 lives could be saved every year if almost all teenage girls were given HPV vaccinations, experts say. More

And Finally... The U.S. government says Bayer makes unproven statements about the health benefits of a popular probiotic. More

Suggested Articles

Which rollouts might suffer most? Those that treat chronic diseases, require doctors to administer them or face current competition, analysts say.

The Cannes Lions canceled its advertising creativity conference for 2020 after media reports that many large ad agencies planned to opt out.

Merck’s Keytruda went up against chemo in a head-to-head colorectal cancer battle—and won.